Pain Clinical Trial
Official title:
The Effects of Pain and the Memory of Pain on Autonomic and Neuromuscular Function
The prevalence of chronic pain has been estimated at 30% in the US and these values may
under report the true prevalence of people who experience long term pain as additional
research has shown that 73% will have a reoccurrence of symptoms within 12 months of the
original injury indicating that while the pain and symptoms may resolve, additional
impairments or issues may underlie the symptoms.
Biopsychosocial factors such as depression, post traumatic stress, anxiety, pain
catastrophizing, and negative emotions have been closely linked to pain and can influence a
patient's pain perceptions. Along these lines, the memory of past experiences and trauma
potentially play a large role in these biopsychosocial responses. Research is evolving and a
strong correlation has been established between chronic pain and prior history of trauma or
abuse and also non-traumatic incidents such as motor vehicle accidents and injuries/surgical
procedures. This has led to speculation and research that explores how a variety of life
events may become stimulants for long-term alterations in the processing and manifestation
of pain and how they may have an enduring impact on physical health outcomes.
The proposed research will add to the body of knowledge underlying the association between
pain, memory, autonomic system, and neuromuscular function. The goal of this project is to
study the relationship between pain memory systems, specifically acute pain, short-term
memory of pain, and long term pain memory, and their effects upon neuromuscular and
autonomic system responses in the body.
Study Design This study will utilize a repeated measures quasi-experimental case control
design structure. Subjects will be placed into two groupings, those who have a history of
prior lower extremity injury and those who have no history of lower extremity injury. The
two groupings will be age and gender matched. Subjects who have no prior history of lower
extremity injury will be matched to subjects with a prior history of injury. There will be
an equivalent number of participants per group with similar demographic information in both
groups in order to reduce the number of variables influencing the results of the experiment.
Within each of these groupings, specific interventions will be clustered and performed as a
set. These clusters of interventions will be randomized to minimize internal testing error.
Both groups of participants will be exposed to the same interventions (baseline, pain
pressure, visualization of pain pressure and prior injury, and mental challenge test).
Investigators responsible for testing and outcome measurement will be blinded to the
groupings of subjects (past history or no prior history of injury). It is anticipated that
the testing, including initial set up, will take between 60 and 75 minutes. All testing will
take place at the Mount St. Mary's College physical therapy exercise and research lab or in
a private room at Knight Physical Therapy Inc.
Study Methods Initial Set Up (25 minutes) Upon commencement of the study, subjects will be
asked to fill out the Tampa Kinesiophobia Questionnaire, Fear Avoidance Belief
Questionnaire, Fear of Pain Scale, Pain Catastrophizing Scale, and the Vividness of Visual
Imagery Questionnaire. This should take approximately 10 minutes. Following completion of
these questionnaires, they will be introduced to the investigators and then asked to lie
supine upon the treatment table. A pillow will be placed under their head for comfort.
Surface EMG rRecording electrodes will be placed upon the belly of the tibialis anterior
muscle. An electrode will be placed upon the medial tibia and will serve as a ground for the
other two electrodes. Placement of electrodes will correspond to the side of injury (i.e.
prior injury to the right ankle would result in electrode placement on the right tibialis
anterior and right anterior deltoid muscles). In subjects without history of injury, side of
electrode placement will be predetermined and randomized. Also at this time, subjects with a
prior history of injury will be asked to identify the location of the injury. The tester
will then palpate the area of previous injury and will locate the tender point in this area.
This point will be marked with a pen for later use. In subjects with no prior injury, the
anterior talofibular ligament, the lateral knee joint line, or the lateral belly of the
gastrocnemius muscle will be located and marked on the side of testing. The site will be
randomized so as to blind testers. Testers will be informed of the side to be tested through
the sealed envelope that is opened prior to testing. They will be blinded as to prior injury
grouping.
At this point, the subject will be walked through the procedure and an initial pain pressure
threshold measurement will be taken and a simulated break test (see below for description of
break test) will be performed at the foot / ankle in order to familiarize the subject with
the test procedures and also to ensure that all equipment is functioning optimally. This
process should take approximately 10 minutes.
Following this procedure, a timer will be set and the subject will rest in this position for
five minutes to acclimate to the environment and to normalize their autonomic system.
Autonomic System Response (10 minutes) Following the five-minute acclimation period, heart
rate variability (HRV) data will be recorded, marked, and used as a baseline measurement.
The HRV data will be collected throughout each testing procedure. Initially, at the site of
previous injury (or randomized pressure site for subjects with no prior history of injury),
the tester will use their thumb to apply pressure to the site. The pressure will increase
until the subject reports their maximal pain level. Prior to the application of pressure,
the subject will be informed that they are to experience the maximum pain tolerable and to
inform the tester when that level is reached. The subject will next be instructed to notify
the testers when they have reached the maximum tolerable pain. Once achieve, the pressure
will be maintained for 10 seconds in order to get a baseline HRV recording. After 10
seconds, the pressure will be released and the HRV recording will be marked. At this time,
the subject will be asked to report their level of pain on a scale of 1 to 10. The subject
will then rest for three minutes to return their HRV to baseline values. At this point, the
subject will be instructed to close their eyes and imagine the pain pressure in their leg
that was just applied. HRV and pain values will be marked and recorded. The subject will
rest for another three minutes and then they will once again be asked to close their eyes.
In this instance, they will be asked to visualize the details of their prior injury. In
subjects with no prior injury, they will asked to visualize the muscles, bone, and blood
flow of their tibia. Like before, HRV and pain values will be marked and recorded. Following
another three minute rest period, the subject will be asked to complete a mental challenge
test. This test will require subjects to count backwards as quickly as possible from 100 by
7. HRV and pain values will be marked and recorded. With this test, and with all testing,
the subject will be allowed to withdrawal from the test for any reason and without
repercussions.
Pressure Pain Threshold (10 minutes) The amount of pain and the force required to elicit the
pain response will be applied and monitored by a Wagner Force Ten™ FDX Digital Force Gauge
Pain Algometer. The algometer is a device designed to measure sensitiveness to pressure and
in pain studies; the algometer is used to measure sensitiveness to pain as a product of
pressure. The Wagner Force Ten Digital Algometer is a portable unit with a small 1
cm2-rubberized tip capable of applying pressures up to 50 lbs./ft. The unit is capable of
remembering multiple data points and storing peak force and force-averaged data that will be
retrieved after testing for later analysis. During each of the five test components
(Baseline, Pain Pressure, Visualization of Pain Pressure, Visualization of Prior Injury, and
Mental Challenge Test) the testing procedures will be identical to those applied earlier,
except instead of measuring muscle performance or HRV, pain pressure will be recorded. The
tip of the pain algometer will be placed upon the site of prior injury or upon the anterior
talofibular ligament. Pressure will be applied through the algometer and the subject will be
instructed to inform the tester when they first begin to experience pain. This value will be
recorded along with HRV values.
Neuromuscular Response (15 minutes) During the next phase of testing, a small rolled up
towel will be placed under the test ankle. The towel will be utilized to raise the foot from
the table in order to facilitate testing. At this point, the tester will stabilize the lower
extremity by grasping the calf approximately 12 inches above the malleolus. This hand will
provide a counter force to the forces applied by the test hand. In the test hand, a Hoggan
Scientific Microfet 2TM Handheld Muscle Tester will be placed upon the lateral aspect of the
fifth metatarsal bone of the foot. The placement will be proximal on the metatarsal
approximately at the base of the fifth metatarsal bone. The position of the sensor will be
marked to standardize test position and measured for later force measurement purposes. The
subject will be instructed to isometrically resist the force applied by the tester. At this
point, Surface EMG and Force recording will commence simultaneously. The Surface EMG will be
utilized to measure action potential propagation. Surface recording electrodes are placed
upon the skin to measure these action potentials. At no time will needles be utilized to
collect data and therefore, no penetration of the skin is required. The initiation of the
test will also be noted on the HRV recording. A steady but increasing amount of force will
be applied slowly and gradually to the foot in a medially and slightly caudal direction
until the subject can no longer resist the force. This process is called the "break test"
because the muscle is tested until it can no longer resist the force. The subject will rest
for 30 seconds after which the break test and associated data recordings will be repeated
two more times with a 30-second rest period in between tests.
The subject will be allowed to rest for three minutes prior to beginning the next portion of
the study. HRV testing will be started and then the tester as previously described will
place pain pressure upon the site of previous injury. The location of this site has been
previous marked for consistency of application. In subjects with no prior history of injury,
the pressure will be applied to the anterior talofibular ligament. When pain pressure has
reached it's maximal levels, a second tester will perform a break test on the subject.
Following the test, the subject will rest for 30 seconds and the process will be repeated
two more times with a 30 second rest period in between tests. Force, EMG, HRV, and pain
values will be recorded during each of the break tests.
Following a three minute rest period, the subject will asked to visualize the pain pressure
placed upon the leg (or visualize their tibia as previously described) and three break tests
will be performed during the visualization process. Force, EMG, HRV, and pain values will be
recorded during each of the break tests. This process will be repeated for visualization of
prior injury and for the mental challenge test.
;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05559255 -
Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI
|
N/A | |
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04466111 -
Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
|
||
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05868122 -
A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
Completed |
NCT03273114 -
Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain
|
N/A | |
Enrolling by invitation |
NCT06087432 -
Is PNF Application Effective on Temporomandibular Dysfunction
|
N/A | |
Completed |
NCT05508594 -
Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001
|
Phase 2/Phase 3 | |
Recruiting |
NCT03646955 -
Partial Breast Versus no Irradiation for Women With Early Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Completed |
NCT03678168 -
A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries
|
N/A | |
Completed |
NCT03931772 -
Online Automated Self-Hypnosis Program
|
N/A | |
Completed |
NCT03286543 -
Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System
|
N/A | |
Completed |
NCT02913027 -
Can We Improve the Comfort of Pelvic Exams?
|
N/A | |
Terminated |
NCT02181387 -
Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor?
|
Phase 4 | |
Recruiting |
NCT06032559 -
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
|
Phase 3 | |
Active, not recruiting |
NCT03613155 -
Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care
|